Genetically modified mice have been extensively used for analyzing the cellular and genetic events that occur during the multistage progression of neoplastic development. However, in many cases, if not all, it is uncertain to what extend the mouse models faithfully reproduce features observed in the corresponding human conditions1-3. This is largely due to lack of methods for direct comparisons of mouse human tumors at the molecular level. To obtain direct comparison of the molecular features of mouse and human hepatocellular carcinoma (HCC), gene expression patterns of 68 HCC from 7 different mouse models were characterized and compared with 91 human HCC from pre-defined subclasses.Gene expression patterns of HCC from Myc, E2f1, and Myc/E2f1 mice had highest similarity with the better survival group of human HCC, while the expression patterns of Myc/Tgfa and DENA-induced mouse HCC had the highest similarity with the poorer survival group of human HCC. As expected, gene expression patterns of Acox1 knockout and ciprofibrate-induced HCC had highest similarity to each other, but failed to emulate those observed in human HCC. We conclude that our approach, the comparative functional oncogenomics, has the great potential to identify the most appropriate mouse models to study human cancers.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC010036-09
Application #
7049722
Study Section
(LEC)
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
2004
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Matter, Matthias S; Marquardt, Jens U; Andersen, Jesper B et al. (2016) Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype. Hepatology 63:1888-99
Coulouarn, Cedric; Factor, Valentina M; Thorgeirsson, Snorri S (2008) Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology 47:2059-67
van Hagen, J M; van der Geest, J N; van der Giessen, R S et al. (2007) Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams Syndrome. Neurobiol Dis 26:112-24
Martin, Juliette; Magnino, Fabrice; Schmidt, Karin et al. (2006) Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology 130:2179-88
Cavin, Lakita G; Wang, Fang; Factor, Valentina M et al. (2005) Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. Mol Cancer Res 3:403-12
Durkin, Marian E; Avner, Miriam R; Huh, Chang-Goo et al. (2005) DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development. FEBS Lett 579:1191-6
Calvisi, Diego F; Thorgeirsson, Snorri S (2005) Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer. Toxicol Pathol 33:181-4
Karlsson, Goran; Liu, Yingchun; Larsson, Jonas et al. (2005) Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling. Physiol Genomics 21:396-403
Meyer, Kirstin; Lee, Ju-Seog; Dyck, Patricia A et al. (2003) Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis 24:975-84
Arsura, Marcello; Panta, Ganesh R; Bilyeu, Jennifer D et al. (2003) Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene 22:412-25

Showing the most recent 10 out of 11 publications